Tag: FDA approval

FDA Approves Blood Test for Alzheimer’s Pathologies

November 10, 2025

FDA Approves Blood Test for Alzheimer’s Pathologies

Rilzabrutinib Approved: BTK Inhibitor for Immune Thrombocytopenia

September 2, 2025

Rilzabrutinib Approved: BTK Inhibitor for Immune Thrombocytopenia

Rilzabrutinib FDA Approved for Idiopathic Thrombocytopenia Purpura

August 30, 2025

Rilzabrutinib FDA Approved for Idiopathic Thrombocytopenia Purpura

Carla Nester MD MSA FASN – Expert Nephrologist & Transplant Physician

August 1, 2025

Carla Nester MD MSA FASN – Expert Nephrologist & Transplant Physician

Web Analytics